Promore Pharma
16.11.2021 15:07:45 CET | ACCESS Newswire | Press release
STOCKHOLM, SE / ACCESSWIRE / November 16, 2021 / Promore Pharma (STO:PROMO) (FRA:8T0)
Promore Pharma AB (publ) today announced the composition of the Nomination Committee for the Annual General Meeting 2022, which will be held on Tuesday 17 May 2022. The Nomination Committee shall, according to decided principles for the appointment of the Nomination Committee, consist of the Chairman of the Board and representatives for the three largest shareholders in the company.
The main task of the Nomination Committee is to submit proposals for Chairman of the Board and other members of the Board, remuneration for Board work, the election and remuneration of auditors. The Nomination Committee shall be composed of the Chairman of the Board and members appointed by the three largest shareholders in the company based on ownership of the Company as per the end of September 2021.
Accordingly, the following committee members have been appointed:
- Göran Pettersson, Chairman of the Board
- David Sundin, representing Corespring New Technology AB (former Midroc New Technology)
- Henric Rahm, representing PharmaResearch Co. Ltd
- Hans-Peter Ostler, representing a co-registered group of shareholders, with an ownership equivalent to 8.2% of the company
The Nomination Committee's proposals will be presented in the Notice to the AGM 2022 and on the company web site, www.promorepharma.com. Shareholders desiring to submit comments or proposals to the nomination committee can send them via email to info@promorepharma.com.
For additional information, please contact
Jonas Ekblom, CEO
Phone: [+46] 736 777 540
E-mail: jonas.ekblom@promorepharma.com
Erik Magnusson, CFO
Phone: [+46] 708 565 245
E-mail: erik.magnusson@promorepharma.com
Promore Pharmas Certified Adviser is Erik Penser Bank
Tel: [+46] 8-463 83 00
E-mail: certifiedadviser@penser.se
Promore Pharma in brief
Promore Pharma is a biopharmaceutical company specialized in the development of therapeutic peptides. The company's aim is to develop first-in-category pharmaceuticals for indications with high unmet medical needs, where very few efficacious prescription pharmaceuticals are available. Promore Pharma's two projects are undergoing clinical development and have a very strong safety profile since the products are based on endogeneous substances that are administered locally. The leading project, ensereptide (PXL01), that will be used for prevention of post-surgical scarring, is being prepared for a clinical phase II-trial if the peptide can prevent the formation of unesthetical scars on the skin. Ropocamptide (LL-37) has recently been evaluated in a clinical phase IIb study with positive results in patients with venous leg ulcers (VLUs). The product candidates can also be deployed for other indications, such as preventing unfavorable tissue attachments (adhesions) after different kinds of surgical procedures and treatment of diabetic foot ulcers. The company is listed on Nasdaq First North Growth Market.
SOURCE: Promore Pharma
View source version on accesswire.com:
https://www.accesswire.com/673114/Nomination-Committee-Appointed-for-the-Annual-General-Meeting-2022-in-Promore-Pharma
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
OMP Ranked in Highest Two Across All Four Use Cases in the 2026 Gartner(R) Critical Capabilities for Supply Chain Planning Solutions: Process Industries30.4.2026 15:00:00 CEST | Press release
ANTWERPEN, BE / ACCESS Newswire / April 30, 2026 / OMP, a leading provider of AI-powered supply chain planning, has been ranked in highest two across all four Use Cases in the 2026 Gartner® Critical Capabilities for Supply Chain Planning Solutions report for process industries. This report, a companion to the Gartner® Magic Quadrant™, evaluates 16 vendors on Critical Capabilities and real-world Use Cases, helping organizations assess how well solutions support different levels of supply chain planning maturity. This recognition follows OMP's recent position as highest in Ability to Execute and furthest in Completeness of Vision in the 2026 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions: Process Industries. Get the full Gartner® Critical Capabilities report. Consistent strength in real-world planning Use Cases The critical capabilities that most distinguish supply chain planning (SCP) vendors for process industries from each other in 2026 are AI-driven planning and decisio
Karbon-X Advances Sur del Meta REDD+ Project with Biodiversity Partnership30.4.2026 15:00:00 CEST | Press release
Collaboration supports the use of ecological data in project design as demand for high-integrity carbon credits accelerates. CALGARY, AB / ACCESS Newswire / April 30, 2026 / Karbon-X Corp. (OTCQX:KARX) ("Karbon-X" or the "Company"), a vertically integrated climate solutions provider operating across compliance and voluntary carbon markets, today announced the formalization of a strategic partnership with Fundación BioHerencia, a participating landowner of the REDD+ project Sur del Meta currently being implemented in Colombia. The partnership aims to embed biodiversity conservation within the REDD+ project by combining the landowner's conservation expertise with community-based monitoring efforts. The agreement establishes a technical, scientific, and operational framework to support the integration of field-based ecological data into the project's Measurement, Reporting, and Verification (MRV) systems. As a participating landowner within the REDD+ project, BioHerencia owns Harpy Eagle
Datavault AI and Kings Mine Capital Agree to Establish $150 Million+ GoldVault(TM) Tokenization Program30.4.2026 15:00:00 CEST | Press release
Agreement Contemplates Bullion at $3,000 an Ounce to Spot for 24-Month Delivery with $40 Million Projected Profit at $5000 an Ounce. GoldVault™ Tokens Issue at Discount to Spot with Production-Linked Royalty Stream PHILADELPHIA, PA / ACCESS Newswire / April 30, 2026 / Datavault AI Inc. ("Datavault AI" or the "Company") (NASDAQ:DVLT), a provider of data monetization, credentialing, digital engagement, and real-world asset ("RWA") tokenization technologies, and King Mining Capital ("King Mining Capital") today announced that they have entered into a agreement for a multi-component strategic transaction that will combine a Datavault AI equity investment in King Mining Capital, a Datavault AI stock-funded purchase of 20,000 ounces of physical gold bullion, and the launch of a $150 million-plus GoldVault™ tokenization program backed by King Mining Capital's high-grade gold resources. Direct Equity, Physical Bullion, and Stock-Funded Consideration Subject to entering into a definitive agreem
doola Launches Agentic LLC Formation: Start a U.S. Company in Minutes Without Leaving Claude or Replit30.4.2026 14:00:00 CEST | Press release
Start a U.S. Company in Minutes Without Leaving Claude or Replit Founders can go from idea to LLC without ever leaving the tool they're building in doola is the first business formation platform to launch a Model Context Protocol (MCP) integration for LLC formation, enabling founders to start an LLC through a conversation directly in Claude or Replit. The flow takes minutes. No new browser. No context switching. Available to US and non-US founders and developers (no US SSN required). doola has helped more than 15,000 founders in 175+ countries start and scale US businesses, backed by $13M in venture capital from Y Combinator, HubSpot Ventures, Nexus Venture Partners, and other top investors. NEW YORK CITY, NY / ACCESS Newswire / April 30, 2026 / doola, the AI Business-in-a-Box™ for global entrepreneurs, today became the first business formation platform to enable native LLC formation within AI agents. With new MCP integrations for Claude and Replit, founders can now form a Wyoming LLC
GoodData is Now GoodData.AI, Reflecting Its AI-First Direction30.4.2026 11:00:00 CEST | Press release
The brand update marks the company's continued shift toward intelligence-driven analytics. SAN FRANCISCO, CA / ACCESS Newswire / April 30, 2026 / GoodData, the AI-native decision intelligence platform, today announced it is rebranding as GoodData.AI. The rebrand reflects a strategic direction GoodData has been building toward for several years. The platform has been developed around a core conviction: that governed, AI-native analytics is the foundation every serious enterprise needs. The semantic layer, context management, open architecture, composability, agentic frameworks, and analytics-as-code introduced over that period were each a step toward that foundation. "GoodData.AI is the name that reflects both where we've been and where the market is going," said Roman Stanek, CEO and Founder of GoodData.AI. "Enterprises need analytics that AI can operate, govern, and trust at scale. That's what we're built for, and we're moving faster than ever to get customers there." That pace is vis
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom